Insulet (PODD) Other Non-Current Assets (2010 - 2026)
Insulet's (PODD) quarterly Other Non-Current Assets came in at $290.8 million in Q2 2026, down 7.71% on a YoY basis from $315.1 million in Q2 2025, and up 3.64% quarter-over-quarter from $280.6 million in Q1 2026.
Analysis
Insulet (PODD) Other Non-Current Assets (2010 - 2026) Analysis & Trends
Insulet (PODD) has reported Other Non-Current Assets for 17 consecutive years, with $290.8 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Other Non-Current Assets fell 7.71% year-over-year to $290.8 million; the trailing twelve-month figure through Jun 2026 stood at $290.8 million (down 7.71% YoY), and the FY2025 full-year result was $288.2 million, up 58.79% from the prior year.
- Other Non-Current Assets climbed to $290.8 million in Q2 2026 per PODD's latest filing, from $280.6 million in the prior quarter.
- Across five years, Other Non-Current Assets topped out at $318.9 million in Q1 2025 and bottomed at $141.0 million in Q1 2022.
- Historically, Other Non-Current Assets has averaged $215.5 million across 5 years, with a median of $192.2 million in 2023.
- The sharpest annual moves came in 2022 and 2024: Other Non-Current Assets soared 97.93% in 2022, then declined 22.68% in 2024.
- Over 5 years, Other Non-Current Assets stood at $210.0 million in 2022, then declined by 10.38% to $188.2 million in 2023, then decreased by 3.56% to $181.5 million in 2024, then jumped by 58.79% to $288.2 million in 2025, then climbed by 0.9% to $290.8 million in 2026.
- According to Business Quant data, Other Non-Current Assets over the past three periods registered $290.8 million, $280.6 million, and $288.2 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 180.76 Bn | 175.16 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 127.77 Bn | 122.55 Bn | 1.96 Bn | - |
| 3 | Medtronic | 117.20 Bn | 108.39 Bn | 6.34 Bn | 4.32 Bn |
| 4 | Stryker | 104.01 Bn | 100.53 Bn | 4.50 Bn | 3.23 Bn |
| 5 | Boston Scientific | 63.51 Bn | 62.97 Bn | 3.85 Bn | 45.22 Bn |
| 6 | Edwards Lifesciences | 49.80 Bn | 45.55 Bn | 1.35 Bn | 616.40 Mn |
| 7 | Alcon | 33.03 Bn | 31.58 Bn | 1.68 Bn | 434.00 Mn |
| 8 | Dexcom | 32.18 Bn | 30.23 Bn | 830.00 Mn | 273.70 Mn |
| 9 | Steris | 20.71 Bn | 20.23 Bn | 684.20 Mn | 215.10 Mn |
| 10 | Insulet | 9.35 Bn | 8.82 Bn | 562.60 Mn | 290.80 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 290.80 Mn |
| Mar 31, 2026 | 280.60 Mn |
| Dec 31, 2025 | 288.20 Mn |
| Sep 30, 2025 | 188.30 Mn |
| Jun 30, 2025 | 315.10 Mn |
| Mar 31, 2025 | 318.90 Mn |
| Dec 31, 2024 | 181.50 Mn |
| Sep 30, 2024 | 165.90 Mn |
| Jun 30, 2024 | 163.60 Mn |
| Mar 31, 2024 | 187.70 Mn |
| Dec 31, 2023 | 188.20 Mn |
| Sep 30, 2023 | 196.20 Mn |
| Jun 30, 2023 | 211.60 Mn |
| Mar 31, 2023 | 210.60 Mn |
| Dec 31, 2022 | 210.00 Mn |
| Sep 30, 2022 | 178.70 Mn |
| Jun 30, 2022 | 161.90 Mn |
| Mar 31, 2022 | 141.00 Mn |
| Dec 31, 2021 | 106.10 Mn |
| Sep 30, 2021 | 99.60 Mn |